{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T12:13:40Z","timestamp":1794658420795,"version":"4.9.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ucl.2021.07.003","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T23:17:47Z","timestamp":1629847067000},"page":"565-576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Management of Priapism"],"prefix":"10.1016","volume":"48","author":[{"given":"Christian","family":"Ericson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Broderick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ucl.2021.07.003_bib1","first-page":"1318","article-title":"American Urological Association guideline on the management of priapism","volume":"170","author":"Montague","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.ucl.2021.07.003_bib2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0090-4295(01)00941-4","article-title":"Incidence of priapism in the general population","volume":"57","author":"Eland","year":"2001","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ucl.2021.07.003_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1464-4096.2001.01510.x","article-title":"Low-flow priapism: risk factors for erectile dysfunction","volume":"89","author":"El-Bahnasawy","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.ucl.2021.07.003_bib4","unstructured":"Broderick, G.A. Priapism. Campbell - Walsh - Wein. Urology, 12th edition, pp. 1539-1563. Elsevier, copyright 2021."},{"issue":"2","key":"10.1016\/j.ucl.2021.07.003_bib5","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2013.11.008","article-title":"European Association of Urology guidelines on priapism","volume":"65","author":"Salonia","year":"2014","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ucl.2021.07.003_bib6","first-page":"3702","article-title":"Stuttering priapism associated with hereditary spherocytosis","volume":"14","author":"Prabhakaran","year":"2007","journal-title":"Can J Urol"},{"issue":"1 Pt 2","key":"10.1016\/j.ucl.2021.07.003_bib7","first-page":"476","article-title":"Priapism: pathogenesis, epidemiology, and management","volume":"7","author":"Broderick","year":"2010","journal-title":"J\u00a0Sex Med"},{"issue":"7","key":"10.1016\/j.ucl.2021.07.003_bib8","first-page":"990","article-title":"The Hemodynamic Effects of Intracavernosal Phenylephrine for the Treatment of Ischemic Priapism","volume":"15","author":"Sidhu","year":"2018","journal-title":"J\u00a0Sex Med"},{"issue":"1","key":"10.1016\/j.ucl.2021.07.003_bib9","first-page":"9","article-title":"Pharmacologic erection: time-dependent changes in the corporal environment","volume":"6","author":"Broderick","year":"1994","journal-title":"Int J Impot Res"},{"issue":"4","key":"10.1016\/j.ucl.2021.07.003_bib10","first-page":"1275","article-title":"Incidence of priapism in emergency departments in the United States","volume":"190","author":"Roghmann","year":"2013","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.ucl.2021.07.003_bib11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/bju.13717","article-title":"Guideline of guidelines: priapism","volume":"119","author":"Muneer","year":"2017","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ucl.2021.07.003_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00184593","article-title":"Intracavernous prostaglandin E1 in erectile dysfunction","volume":"72","author":"Linet","year":"1994","journal-title":"Clin Investig"},{"issue":"10","key":"10.1016\/j.ucl.2021.07.003_bib13","first-page":"1650","article-title":"Priapism from recreational intracavernosal injections in a high-risk metropolitan community","volume":"16","author":"Zhao","year":"2019","journal-title":"J\u00a0Sex Med"},{"issue":"8","key":"10.1016\/j.ucl.2021.07.003_bib14","first-page":"1579","article-title":"Are we overstating the risk of priapism with oral phosphodiesterase type 5 inhibitors?","volume":"17","author":"Rezaee","year":"2020","journal-title":"J\u00a0Sex Med"},{"issue":"3","key":"10.1016\/j.ucl.2021.07.003_bib15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/JCP.0000000000001039","article-title":"Successful management of methylphenidate or atomoxetine-related priapism during attention-deficit hyperactivity disorder treatment","volume":"40","author":"Karayagmurlu","year":"2020","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.ucl.2021.07.003_bib16","first-page":"88","article-title":"Priapism and sickle-cell anemia: diagnosis and nonsurgical therapy","volume":"9","author":"Broderick","year":"2012","journal-title":"J\u00a0Sex Med"},{"issue":"1","key":"10.1016\/j.ucl.2021.07.003_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0022-5347(17)34928-5","article-title":"Anoxia and corporal smooth muscle dysfunction: a model for ischemic priapism","volume":"151","author":"Broderick","year":"1994","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2021.07.003_bib18","first-page":"92","article-title":"Noncholinergic penile erection in mice lacking the gene for endothelial nitric oxide synthase","volume":"23","author":"Burnett","year":"2002","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.ucl.2021.07.003_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41443-019-0141-z","article-title":"Which patients with ischaemic priapism require further investigation for malignancy?","volume":"32","author":"James Johnson","year":"2020","journal-title":"Int J Impot Res"},{"issue":"4","key":"10.1016\/j.ucl.2021.07.003_bib20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s11934-012-0258-9","article-title":"Stuttering priapism: insights into pathogenesis and management","volume":"13","author":"Morrison","year":"2012","journal-title":"Curr Urol Rep"},{"issue":"7","key":"10.1016\/j.ucl.2021.07.003_bib21","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1464-410X.2011.10367.x","article-title":"Treating stuttering priapism","volume":"108","author":"Kheirandish","year":"2011","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.ucl.2021.07.003_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ajh.10069","article-title":"Short period of administration of diethylstilbestrol in stuttering priapism in sickle cell anemia","volume":"69","author":"Gbadoe","year":"2002","journal-title":"Am J Hematol"},{"issue":"8467","key":"10.1016\/j.ucl.2021.07.003_bib23","first-page":"12","article-title":"Stilboestrol and stuttering priapism in homozygous sickle-cell disease","volume":"2","author":"Serjeant","year":"1985","journal-title":"Lancet"},{"issue":"2 Pt 1","key":"10.1016\/j.ucl.2021.07.003_bib24","first-page":"475","article-title":"Gonadotropin-releasing hormone analogues in the treatment of sickle cell anemia-associated priapism","volume":"150","author":"Levine","year":"1993","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.ucl.2021.07.003_bib25","first-page":"1401","article-title":"Ketoconazole and prednisone to prevent recurrent ischemic priapism","volume":"182","author":"Abern","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2021.07.003_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.21037\/tau.2019.07.15","article-title":"Dutasteride in the long-term management of stuttering priapism","volume":"9","author":"Baker","year":"2020","journal-title":"Transl Androl Urol"},{"issue":"1","key":"10.1016\/j.ucl.2021.07.003_bib27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0090-4295(01)01492-3","article-title":"Antiandrogens in the treatment of priapism","volume":"59","author":"Dahm","year":"2002","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.ucl.2021.07.003_bib28","first-page":"152","article-title":"Management of recurrent priapism with epinephrine self-injection and gonadotropin-releasing hormone analogue","volume":"153","author":"Steinberg","year":"1995","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.ucl.2021.07.003_bib29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0090-4295(96)00027-1","article-title":"Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine","volume":"47","author":"Virag","year":"1996","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.ucl.2021.07.003_bib30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1464-410X.1997.00285.x","article-title":"Treatment of intermittent idiopathic priapism with oral terbutaline","volume":"80","author":"Ahmed","year":"1997","journal-title":"Br J Urol"},{"issue":"6","key":"10.1016\/j.ucl.2021.07.003_bib31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.5152\/tud.2020.20144","article-title":"High-flow priapism after T-shunt and tunneling in a patient with ischemic priapism","volume":"46","author":"Vagnoni","year":"2020","journal-title":"Turk J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2021.07.003_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.sxmr.2019.01.001","article-title":"Management of priapism: a contemporary review","volume":"8","author":"Mishra","year":"2020","journal-title":"Sex Med Rev"},{"issue":"2","key":"10.1016\/j.ucl.2021.07.003_bib33","first-page":"248","article-title":"Intracavernosal irrigation by cold saline as a simple method of treating iatrogenic prolonged erection","volume":"2","author":"Ateyah","year":"2005","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.ucl.2021.07.003_bib34","first-page":"1699","article-title":"T\u00a0shaped shunt and intracavernous tunneling for prolonged priapism","volume":"181","author":"Brant","year":"2009","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2021.07.003_bib35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/smrj.37","article-title":"Management of recurrent ischemic priapism 2014: a complex condition with devastating consequences","volume":"3","author":"Hoeh","year":"2015","journal-title":"Sex Med Rev"},{"issue":"4","key":"10.1016\/j.ucl.2021.07.003_bib36","first-page":"1171","article-title":"Corporal \"snake\" maneuver: corporoglanular shunt surgical modification for ischemic priapism","volume":"6","author":"Burnett","year":"2009","journal-title":"J\u00a0Sex Med"},{"issue":"1","key":"10.1016\/j.ucl.2021.07.003_bib37","first-page":"164","article-title":"The efficacy of the T-shunt procedure and intracavernous tunneling (snake maneuver) for refractory ischemic priapism","volume":"191","author":"Zacharakis","year":"2014","journal-title":"J\u00a0Urol"},{"issue":"8","key":"10.1016\/j.ucl.2021.07.003_bib38","first-page":"1290","article-title":"Anatomic and Functional Outcome Following Distal Shunt and Tunneling for Treatment Ischemic Priapism: A Single-Center Experience","volume":"16","author":"Orta\u00e7","year":"2019","journal-title":"J\u00a0Sex Med"},{"issue":"5","key":"10.1016\/j.ucl.2021.07.003_bib39","first-page":"797","article-title":"Penoscrotal decompression-promising new treatment paradigm for refractory ischemic priapism","volume":"15","author":"Fuchs","year":"2018","journal-title":"J\u00a0Sex Med"},{"issue":"4","key":"10.1016\/j.ucl.2021.07.003_bib40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/bju.15127","article-title":"Favourable multi-institutional experience with penoscrotal decompression for prolonged ischaemic priapism","volume":"126","author":"Baumgarten","year":"2020","journal-title":"BJU Int"},{"issue":"11","key":"10.1016\/j.ucl.2021.07.003_bib41","first-page":"2260","article-title":"Clinical outcomes of periprocedural antithrombotic therapy in ischemic priapism management","volume":"17","author":"Ramstein","year":"2020","journal-title":"J\u00a0Sex Med"},{"issue":"9","key":"10.1016\/j.ucl.2021.07.003_bib42","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1046\/j.1464-410X.2002.03058.x","article-title":"The management of low-flow priapism with the immediate insertion of a penile prosthesis","volume":"90","author":"Rees","year":"2002","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ucl.2021.07.003_bib43","first-page":"296","article-title":"Penile prosthesis surgery: a review of prosthetic devices and associated complications","volume":"4","author":"Sadeghi-Nejad","year":"2007","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.ucl.2021.07.003_bib44","first-page":"573560","article-title":"Penile prosthesis: what should we do about complications?","author":"Bettocchi","year":"2008","journal-title":"Adv Urol"},{"key":"10.1016\/j.ucl.2021.07.003_bib45","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.eururo.2008.09.044","article-title":"The immediate insertion of a penile prosthesis for acute ischaemic priapism","volume":"56","author":"Ralph","year":"2009","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ucl.2021.07.003_bib46","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0090-4295(97)00045-9","article-title":"Post-traumatic priapism treated with selective cavernosal artery ligation","volume":"49","author":"Shapiro","year":"1997","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.ucl.2021.07.003_bib47","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2164\/jandrol.110.011890","article-title":"Daily phosphodiesterase type 5 inhibitor therapy as rescue for recurrent ischemic priapism after failed androgen ablation","volume":"32","author":"Pierorazio","year":"2011","journal-title":"J Androl"},{"issue":"5","key":"10.1016\/j.ucl.2021.07.003_bib48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/14728222.2020.1745188","article-title":"Mechanisms underlying priapism in sickle cell disease: targeting and key innovations on the preclinical landscape","volume":"24","author":"Musicki","year":"2020","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"10.1016\/j.ucl.2021.07.003_bib49","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI33467","article-title":"Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling","volume":"118","author":"Mi","year":"2008","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.ucl.2021.07.003_bib50","doi-asserted-by":"crossref","first-page":"C916","DOI":"10.1152\/ajpcell.00656.2008","article-title":"The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway","volume":"297","author":"Kanika","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.ucl.2021.07.003_bib51","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/andr.12442","article-title":"Testosterone replacement in transgenic sickle cell mice controls priapic activity and upregulates PDE5 expression and eNOS activity in the penis","volume":"6","author":"Musicki","year":"2018","journal-title":"Andrology"},{"issue":"6","key":"10.1016\/j.ucl.2021.07.003_bib52","first-page":"179","article-title":"Testosterone Replacement Therapy in Adolescents With Sickle Cell Disease Reverses Hypogonadism Without Promoting Priapism: A Case Report","volume":"3","author":"Morrison","year":"2015","journal-title":"Urol Case Rep"},{"issue":"5","key":"10.1016\/j.ucl.2021.07.003_bib53","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.urology.2009.04.071","article-title":"Treatment of recurrent priapism in sickle cell anemia with finasteride: a new approach","volume":"74","author":"Rachid-Filho","year":"2009","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.ucl.2021.07.003_bib54","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/bjh.12199","article-title":"How I manage priapism due to sickle cell disease","volume":"160","author":"Olujohungbe","year":"2013","journal-title":"Br J Haematol"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009401432101867X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009401432101867X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:40:25Z","timestamp":1758807625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009401432101867X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S009401432101867X"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2021.07.003","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Priapism","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2021.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}